Spain Pharmaceutical Manufacturing Market Size & Outlook

The pharmaceutical manufacturing market in Spain is expected to reach a projected revenue of US$ 26,951.9 million by 2030. A compound annual growth rate of 10.3% is expected of Spain pharmaceutical manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$13,559.1
Forecast, 2030 (US$M)
$26,951.9
CAGR, 2024 - 2030
10.3%
Report Coverage
Spain

Spain pharmaceutical manufacturing market, 2018-2030 (US$M)

Spain

Spain pharmaceutical manufacturing market highlights

  • The Spain pharmaceutical manufacturing market generated a revenue of USD 13,559.1 million in 2023 and is expected to reach USD 26,951.9 million by 2030.
  • The Spain market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
  • In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
  • Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.

Pharmaceutical manufacturing market data book summary

Market revenue in 2023USD 13,559.1 million
Market revenue in 2030USD 26,951.9 million
Growth rate10.3% (CAGR from 2023 to 2030)
Largest segmentConventional drugs (small molecules)
Fastest growing segmentConventional Drugs (Small Molecules)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)
Key market players worldwideRoche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova

Other key industry trends

  • In terms of revenue, Spain accounted for 2.7% of the global pharmaceutical manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany pharmaceutical manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 37,683.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical Manufacturing Market Companies

Name Profile # Employees HQ Website

Spain pharmaceutical manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.


Conventional drugs (small molecules) was the largest segment with a revenue share of 51.06% in 2023. Horizon Databook has segmented the Spain pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.


  • Spain Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Million, 2018-2030)
    • Biologics & Biosimilars (Large Molecules)
      • Monoclonal Antibodies
      • Vaccines
      • Cell & Gene Therapy
      • Others
    • Conventional Drugs (Small Molecules)
  • Spain Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Million, 2018-2030)
    • Outsource
    • In-house
  • Spain Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Million, 2018-2030)
    • Tablets
    • Capsules
    • Injectables
    • Sprays
    • Suspensions
    • Powders
    • Other Formulations
  • Spain Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Topical
    • Parenterals
    • Inhalations
    • Other Routes of Administration
  • Spain Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Million, 2018-2030)
    • Cardiovascular Diseases
    • Pain
    • Diabetes
    • Cancer
    • Respiratory Diseases
    • Other Diseases
  • Spain Pharmaceutical Manufacturing Prescription Requirements Outlook (Revenue, USD Million, 2018-2030)
    • Prescription Medicines
    • Over-the-counter (OTC) Medicines
  • Spain Pharmaceutical Manufacturing Age Type Outlook (Revenue, USD Million, 2018-2030)
    • Children & Adolescents
    • Adults
    • Geriatric
  • Spain Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Million, 2018-2030)
    • Retail
    • Non-retail

Reasons to subscribe to Spain pharmaceutical manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain pharmaceutical manufacturing market databook

  • Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain pharmaceutical manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Spain pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain pharmaceutical manufacturing market size, by molecule type, 2018-2030 (US$M)

Spain Pharmaceutical Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Spain pharmaceutical manufacturing market size, by molecule type, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more